Versor Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,126
Closed -$436K 743
2025
Q3
$436K Sell
17,126
-37,800
-69% -$933K 0.08% 364
2025
Q2
$1.33M Buy
54,926
+46,626
+562% +$1.09M 0.23% 94
2025
Q1
$210K Sell
8,300
-13,200
-61% -$345K 0.03% 650
2024
Q4
$570K Buy
+21,500
New +$583K 0.1% 329
2024
Q3
Sell
-44,400
Closed -$1.24M 934
2024
Q2
$1.24M Buy
+44,400
New +$1.22M 0.23% 102
2023
Q2
Sell
-21,183
Closed -$864K 784
2023
Q1
$864K Buy
+21,183
New +$915K 0.11% 150
2022
Q4
Sell
-87,024
Closed -$3.81M 913
2022
Q3
$3.81M Buy
87,024
+18,824
+28% +$915K 0.23% 32
2022
Q2
$3.58M Buy
68,200
+25,500
+60% +$1.3M 0.14% 47
2022
Q1
$2.21M Buy
42,700
+10,000
+31% +$519K 0.08% 49
2021
Q4
$1.93M Sell
32,700
-26,700
-45% -$1.32M 0.06% 53
2021
Q3
$2.56M Sell
59,400
-16,000
-21% -$709K 0.08% 52
2021
Q2
$2.95M Buy
75,400
+47,200
+167% +$1.84M 0.1% 44
2021
Q1
$1.02M Buy
+28,200
New +$1M 0.06% 62
2020
Q4
Sell
-30,250
Closed -$1.05M 232
2020
Q3
$1.05M Buy
30,250
+19,605
+184% +$687K 0.09% 70
2020
Q2
$330K Buy
+10,645
New +$362K 0.03% 128
2019
Q1
Sell
-15,361
Closed -$636K 315
2018
Q4
$636K Buy
15,361
+1,448
+10% +$60.1K 0.15% 130
2018
Q3
$582K Buy
+13,913
New +$536K 0.22% 135
2017
Q4
Sell
-5,969
Closed -$202K 279
2017
Q3
$202K Sell
5,969
-1,265
-17% -$40.7K 0.07% 169
2017
Q2
$231K Buy
+7,234
New +$228K 0.06% 150

Other funds holding PFE

Versor Investments's PFE Position: Q4 2025 in Review

Versor Investments sold out of Pfizer (PFE) in Q4 2025, closing a stake of 17,126 shares — an estimated $436K sold.

Versor Investments first reported a position in PFE in Q2 2017 and held it in 19 quarters. The position peaked at $3.81M in Q3 2022. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Versor Investments reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 17,126 Pfizer shares in Q4 2025, an estimated $436K.
  • Versor Investments first reported a position in Pfizer in Q2 2017 and held it in 19 quarters.
  • Versor Investments's Pfizer position peaked at $3.81M in Q3 2022.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.